Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Eric Horwitz

Email
Center AffiliationsMolecular Therapeutics

Publications (207) (print view)

no pagination
Horwitz EM, Thames HD, Kuban DA, Levy LB, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Hanks GE, Zietman AL. Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: A multi-institutional pooled analysis. Journal of Urology. 2005 Mar;173(3):797-802.
Jacob R, Hanlon AL, Horwitz EM, Movsas B, Uzzo RG, Pollack A. Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement. International Journal of Radiation Oncology Biology Physics. 2005 Mar;61(3):695-701.
Kramer NM, Horwitz EM, Cheng J, Ridge JA, Feigenberg SJ, Cohen RB, Nicolaou N, Sherman EJ, Babb JS, Damsker JA, Langer CJ. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatln and paclitaxel chemotherapy from two prospective phase I and II studies. Head and Neck. 2005 Jan;27(5):406-14.
Kuban D, Thames H, Levy L, Horwitz E, Kupelian P, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A. Failure definition-dependent differences in outcome following radiation for localized prostate cancer: Can one size fit all?. International Journal of Radiation Oncology Biology Physics. 2005 Feb;61(2):409-14.
Kupelian P, Kuban D, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: The combined experience of nine institutions in patients treated in 1994 and 1995. International Journal of Radiation Oncology Biology Physics. 2005 Feb;61(2):415-9.
Kupelian P, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A, Kuban D. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era. International Journal of Radiation Oncology Biology Physics. 2005 Nov;63(3):795-9.
Manne SL, Ostroff JS, Winkel G, Fox K, Grana G, Miller E, Ross S, Frazier T, Buyyounouski MK, Hanlon AL, Eisenberg DF, Horwitz EM, Feigenberg SJ, Uzzo RG, Pollack A, Morrow M, Chen JQ, Yager JD, Russo J, Bassi DE, Fu J, Lopez de Cicco R, Klein-Szanto AJ, Devlin J, Sherman E, Altomare DA, Vaslet CA, Skele KL, De Rienzo A, Devarajan K, Jhanwar SC, McClatchey AI, Kane AB, Testa JR, Murphy ME, Langer CJ, Mehta MP, Viterbo R, Greenberg RE, Al-Saleem T, Canutescu AA, Dunbrack RL, Serebriiskii IG, Fang R, Latypova E, Hopkins R, Vinson C, Joung JK, Golemis EA. Couple-focused group intervention for women with early stage breast cancer. . J Consult Clin Psychol. 2005 Sep 15;73(4):634-46.
Paskalev K, Feigenberg S, Jacob R, McNeeley S, Horwitz E, Price R, Ma C, Pollack A. Target localization for post-prostatectomy patients using CT and ultrasound image guidance. Journal of Applied Clinical Medical Physics. 2005 Jan;6(4):40-9.
Pollack A, Price RA, Dong L, Feigenberg S, Horwitz E. Intact prostate cancer: overview. In: Mundte AJ, Roeske JC, editors. Intensity Modulated Radiation Therapy - A Clinical Perspective. Hamilton, ON: BC Decker Inc.; 2005. p. 336-448.
Pollack A, Price RA, Dong L, Feigenberg S, Horwitz E. Intact prostate cancer: case study. In: Mundte AJ, Roeske JC, editors. Intensity Modulated Radiation Therapy - A Clinical Perspective. Hamilton, ON: BC Decker Inc.; 2005. p. 459-63.
Ridge JA, Glisson BS, Horwitz E, Lango M. Head and Neck Cancer. In: Pazdur R, Coia LR, Hoskins WJ, Wagman LD, editors. Cancer Management: A Multidisciplinary Approach. Manhasset: CMP Healthcare Media; 2005. p. 43-90.
Vicini FA, Vargas C, Abner A, Kestin L, Horwitz E, Martinez A. Limitations in the use of serum prostate specific antigen levels to monitor patients after treatment for prostate cancer. Journal of Urology. 2005 Jan;173(5):1456-62.
Buyyounouski MK, Hanlon AL, Price RA, Horwitz EM, Feigenberg SJ, Pollack A. In regard to Selek et al. Erectile dysfunction and radiation dose to penile base structures: A lack of correlation (Int J Radiat Oncol Biol Phys) 2004;59 : 1039-1046. International Journal of Radiation Oncology Biology Physics. 2004 Dec;60(5):1664-5.
Buyyounouski MK, Horwitz EM, Hanlon AL, Uzzo RG, Pollack A. Re: Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: Results from the search database - S.J. Freedland, J.C. Presti, Jr., M.K Terris, C.J. Kane, W.J. Aronson, F. Dorey and C.L. Amling for the SEARCH Database Study Group - J Urol, 169 : 2129-2135, 2003. Journal of Urology. 2004 Mar;171(3):1246-7.
Buyyounouski MK, Horwitz EM, Price RA, Hanlon AL, Uzzo RG, Pollack A. Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2004 Mar;58(3):743-9.
Buyyounouski MK, Horwitz EM, Uzzo RG, Price RA, McNeeley SW, Azizi D, Hanlon AL, Milestone BN, Pollack A. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy. International Journal of Radiation Oncology, Biology, Physics. 2004 Aug;59(5):1383-91.
Chism DB, Hanlon AL, Horwitz EM, Feigenberg SJ, Pollack A. A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy. International Journal of Radiation Oncology Biology Physics. 2004 Jun;59(2):380-5.
Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, Horwitz EM, Glisson BS, Nabell L, Cooper JS, Demas W, Gore E. Preliminary results of Radiation Therapy Oncology Group 97-03: A randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. Journal of Clinical Oncology. 2004 Jul;22(14):2856-64.
Hanlon AL, Horwitz EM, Hanks GE, Pollack A. Short-term androgen deprivation and PSA doubling time: their association and relationship to disease progression after radiation therapy for prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 2004 Jan;58(1):43-52.
Horwitz EM, Feigenberg SJ, Pollack A, Hanks GE, Uzzo RG. Androgen suppression plus radiation therapy for prostate cancer. JAMA-Journal of the American Medical Association. 2004 Nov 03;292(17):2084-5.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

Eric Horwitz Sparkline Graph

Graph Interactions

Co-Authors:

Similar Investigators:


Keywords (MeSH):


Last updated on Wednesday, September 06, 2017